These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacological modulation of ApoA- and ApoB-containing lipoproteins. Bard JM Prog Lipid Res; 1991; 30(2-3):267-74. PubMed ID: 1823945 [No Abstract] [Full Text] [Related]
3. Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome. Rabelink AJ; Hené RJ; Erkelens DW; Joles JA; Koomans HA Lancet; 1988 Dec; 2(8624):1335-8. PubMed ID: 2904053 [TBL] [Abstract][Full Text] [Related]
4. Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins. Xie Y; Nassir F; Luo J; Buhman K; Davidson NO Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G735-46. PubMed ID: 12816761 [TBL] [Abstract][Full Text] [Related]
5. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I. Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804 [TBL] [Abstract][Full Text] [Related]
6. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate. Roe DA Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239 [No Abstract] [Full Text] [Related]
7. Effect of fluvastatin on plasma apolipoprotein-B-containing particles, including lipoprotein(a). European Fluvastatin Study Group. Dallongeville J; Fruchart JC; Pfister P; Bard JM J Intern Med Suppl; 1994; 736():95-101. PubMed ID: 7986315 [TBL] [Abstract][Full Text] [Related]
8. Treatment of essential hyperlipidaemia. Fredrickson DS; Levy RI Lancet; 1970 Jan; 1(7639):191-2. PubMed ID: 4189261 [No Abstract] [Full Text] [Related]
9. Measurement of changes in human apolipoprotein B levels in triglyceride-rich lipoproteins following a fatty meal. Curtin AA; Johnson AH; Tomkin G; Collins P Biochem Soc Trans; 1994 Feb; 22(1):35S. PubMed ID: 8206257 [No Abstract] [Full Text] [Related]
10. Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action. Sacks FM; Dzau VJ Am J Med; 1986 Feb; 80(2A):71-81. PubMed ID: 3080883 [TBL] [Abstract][Full Text] [Related]
11. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Schneeman BO; Kotite L; Todd KM; Havel RJ Proc Natl Acad Sci U S A; 1993 Mar; 90(5):2069-73. PubMed ID: 8446630 [TBL] [Abstract][Full Text] [Related]
12. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia. Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788 [TBL] [Abstract][Full Text] [Related]
13. Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group. Bard JM; Ose L; Hagen E; Duriez P; Pfister P; Fruchart JC; Dallongeville J Am J Cardiol; 1995 Jul; 76(2):65A-70A. PubMed ID: 7604802 [TBL] [Abstract][Full Text] [Related]
14. [Changes in the levels and composition of lipoproteins and apolipoproteins of blood plasma in patients with ischemic heart disease after hemosorption]. Torkhovskaia TI; Khalilov EM; Oleĭnik IA; Kliuchnikova ZhI; Klimov AN Kardiologiia; 1989 Oct; 29(10):60-4. PubMed ID: 2615161 [TBL] [Abstract][Full Text] [Related]
16. Effect of pravastatin on apolipoproteins B and C-III in very-low-density lipoproteins and low-density lipoproteins. Sacks FM; Alaupovic P; Moye LA Am J Cardiol; 2002 Jul; 90(2):165-7. PubMed ID: 12106851 [No Abstract] [Full Text] [Related]
17. Diet and drug therapy for hyperlipoproteinemia. Maha GE Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828 [No Abstract] [Full Text] [Related]
18. Lipids, lipoproteins and apolipoproteins AI, AII, B, CII, CIII and E in newborns. Averna MR; Barbagallo CM; Di Paola G; Labisi M; Pinna G; Marino G; Dimita U; Notarbartolo A Biol Neonate; 1991; 60(3-4):187-92. PubMed ID: 1797121 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375 [TBL] [Abstract][Full Text] [Related]
20. Relationship of blood rheology to lipoprotein profile during normal pregnancies and those with intrauterine growth retardation. Muñoz A; Uberos J; Molina A; Valenzuela A; Cano D; Ruiz C; Molina Font JA J Clin Pathol; 1995 Jun; 48(6):571-4. PubMed ID: 7665704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]